Canadian Healthcare Technology covers the launch of a McMaster University led clinical trial evaluating NodeAI's real-time decision support platform for EBUS-TBNA lung cancer staging, with UHN's Toronto General Hospital as a key site. Read the full article here.
NodeAI featured in Canadian Healthcare Technology
Previous
Previous
NodeAI Named a Finalist for Falling Walls Venture 2026
Next
Next